A

Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408

Watchlist Manager
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Watchlist
Price: 12.64 CNY -5.81% Market Closed
Market Cap: 5.1B CNY
Have any thoughts about
Anhui Huaren Health Pharmaceutical Co Ltd?
Write Note

Anhui Huaren Health Pharmaceutical Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Anhui Huaren Health Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison

Comparables:
D
603233
603883
603939
301017
002727

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Capital Expenditures
-ÂĄ216.3m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Capital Expenditures
-ÂĄ1.8B
CAGR 3-Years
-24%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Capital Expenditures
-ÂĄ656.5m
CAGR 3-Years
-12%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Capital Expenditures
-ÂĄ776.2m
CAGR 3-Years
-2%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Capital Expenditures
-ÂĄ181.6m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Capital Expenditures
-ÂĄ268.2m
CAGR 3-Years
6%
CAGR 5-Years
-9%
CAGR 10-Years
-5%

See Also

What is Anhui Huaren Health Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-216.3m CNY

Based on the financial report for Dec 31, 2023, Anhui Huaren Health Pharmaceutical Co Ltd's Capital Expenditures amounts to -216.3m CNY.

What is Anhui Huaren Health Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-58%

Over the last year, the Capital Expenditures growth was -106%. The average annual Capital Expenditures growth rates for Anhui Huaren Health Pharmaceutical Co Ltd have been -58% over the past three years .

Back to Top